- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05968300
Getting INFORMED and Living Well Among Asian Americans in California
November 20, 2024 updated by: University of California, San Francisco
Getting INFORMED and Living Well: A Demonstration Project to Facilitate Pandemic Recovery Among Asian Americans in California
The project is to facilitate pandemic recovery by promoting emotional wellness among Asian Californians.
The intervention includes a 6-week program in which participants may choose to receive text only or text + Lay Health Worker outreach targeting 600 self-identified Asian Americans residing in California who speak/read English, Chinese, Korean, Hmong, or Vietnamese.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Investigators will conduct a non-randomized intervention trial (preference trial).
Research participants involved in the trial will include 20 lay health workers (LHWs) and 600 trial participants with intervention delivered via SMS text messaging (for all participants), and the intervention group will receive educational intervention outreach from an LHW via Zoom or mutually agreed video conferencing online venues, and by telephone or instant messaging.
Participants will choose which group they are in, SMS text messaging only or SMS text messaging plus educational outreach from an LHW.
Study Type
Interventional
Enrollment (Actual)
616
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Fresno, California, United States, 93727
- The Fresno Center
-
San Francisco, California, United States, 94143
- University of California, San Francisco
-
San Francisco, California, United States, 94133
- Chinese Community Health Resource Center
-
San Jose, California, United States, 95131
- Immigrant Resettlement & Cultural Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
i) age 18 and older
ii) speak Chinese, English, Hmong, Korean, or Vietnamese
iii) self-identify as Asian American
iv) have access to a mobile phone to receive SMS text messages
Exclusion Criteria:
- unwilling to receive SMS text messages from the project
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: INFORMED-Living Well
INFORMED-Living Well consists of two components: 1) LHW outreach support providing responsive education and support; and 2) a 6-week automated SMS text messaging.
The LHW educational outreach component includes 2 small group educational sessions with 2-8 participants.
Participants will also receive a weekly SMS Text or instant message on managing emotional wellness within and beyond the context of the COVID-19 pandemic over 6 weeks.
In addition, participants will receive as-needed messages on updates of COVID-19 or other situations that may introduce new worries and tragic culturally-based traumatic events.
|
1) LHW outreach support providing responsive education and support; and 2) a 6-week automated SMS text messaging
|
|
Active Comparator: Text Messaging Only
Participants will have a 6-week SMS text messaging program identical to that received by the INFORMED-Living Well participants.
|
A 6-week automated SMS text messaging
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in decisional conflict scale (SURE) scores
Time Frame: Baseline and 8-week follow-up
|
Self-assessed perceptions of decision conflict will be assessed using the 4-item Decision Conflict Scale (SURE).
Scores on the SURE scale range from 0 to 4, with higher scores indicating less decisional conflict.
A score of less than 4 indicates decisional conflict.
|
Baseline and 8-week follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in proportion of participants who have Intention to seek help for mental health
Time Frame: Baseline and 8-week follow-up
|
We will use a survey item to assess participants' intention to seek help for mental health issues when needed.
A response will be 0 (No) or 1 (Yes).
|
Baseline and 8-week follow-up
|
|
Change in self-reported emotional wellness outcome
Time Frame: Baseline and 8-week follow-up
|
We will use the four-item Patient Health Questionnaire (PHQ4) for measuring anxiety and depression symptoms.
Scores are rated as normal (0-2), mild (3-5), moderate (6-8), and severe (9-12).
Total score 3 or higher for the first 2 questions suggests anxiety, and total score 3 or higher for the last 2 questions suggests depression.
|
Baseline and 8-week follow-up
|
|
Change in the percentage of participants' awareness of resources to get help or to learn more about improving emotional wellness
Time Frame: Baseline and 8-week follow-up
|
We will assess participants' awareness of resources to get help or to learn more about improving emotional wellness.
Two items created for the study will be used: 1) Do you know about "988"?
(Yes, No, Unsure) 2) Do you know where to get help for mental health issues when you need to? (Yes, No, Unsure).
The percentage of participants who answer "yes" to both questions will be assessed.
|
Baseline and 8-week follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Janice Tsoh, PhD, University of California, San Francisco
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 20, 2024
Primary Completion (Actual)
August 31, 2024
Study Completion (Actual)
August 31, 2024
Study Registration Dates
First Submitted
July 20, 2023
First Submitted That Met QC Criteria
July 20, 2023
First Posted (Actual)
August 1, 2023
Study Record Updates
Last Update Posted (Estimated)
November 22, 2024
Last Update Submitted That Met QC Criteria
November 20, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- P0567396
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID-19
-
PfizerActive, not recruitingCOVID-19 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | COVID-19 Vaccines | SARS-CoV-2 Infection, COVID19 | COVID-19 Vaccination | SARS-CoV-2 Infection, COVID-19 | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionUnited States
-
Shanghai Public Health Clinical CenterNot yet recruiting
-
Duke UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Eggensberger OHGBavarian Health and Food Safety Authority (LGL)RecruitingPost COVID-19 Condition | Post COVID-19 | Post COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID-19 Condition (PCC)Germany
-
PfizerRecruitingRespiratory Tract Diseases | COVID-19 | Pneumonia | Lung Diseases | Coronavirus Disease 2019 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | Upper Respiratory Tract Infections | Respiratory Tract Infection | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionBelgium
-
ModeX Therapeutics, An OPKO Health CompanyRecruitingCOVID -19 | COVID-19 (Prevention)United States
-
Lawson Research Institute of St. Joseph'sCanadian Institutes of Health Research (CIHR); Western University, CanadaRecruitingFatigue | Post-COVID-19 Syndrome | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19 | Long-COVID | Post-COVID ConditionCanada
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
RSUP PersahabatanCompletedPost COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID Syndrome Long CovidIndonesia
-
Yang I. PachankisActive, not recruitingCOVID-19 Respiratory Infection | COVID-19 Stress Syndrome | COVID-19 Vaccine Adverse Reaction | COVID-19-Associated Thromboembolism | COVID-19 Post-Intensive Care Syndrome | COVID-19-Associated StrokeChina
Clinical Trials on INFORMED-Living Well
-
University of Texas at TylerCompletedAnxiety | Depressive Symptoms | Emotional DisordersUnited States
-
Scott A. Irwin, MD, PhDCedars-Sinai Medical Center; ProsomaNot yet recruitingDepression | Anxiety | Supportive Care in CancerUnited States
-
University of Sao PauloCompletedSystemic Lupus ErythematosusBrazil
-
McMaster UniversityActive, not recruitingLow Back PainCanada
-
Georgia Southern UniversityCompletedDevelopmental Disabilities | Health Education | Community Health Services | Health Services for Persons With DisabilitiesUnited States
-
Weill Medical College of Cornell UniversityPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamCompletedDiabetes Mellitus | Medication AdherenceUnited States
-
University of ArkansasNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Northwestern... and other collaboratorsCompletedDiabetesUnited States
-
VA Office of Research and DevelopmentCompleted
-
US Department of Veterans AffairsCompleted
-
Centers for Disease Control and PreventionUniversity of North Carolina, Chapel Hill; East Carolina UniversityCompleted